Universitaire Ziekenhuizen Leuven
Universitaire Ziekenhuizen Leuven
Leuven, Belgium10 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease | Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autosomal dominant polycystic kidney disease, cystic kidney disease, hereditary disease, kidney disorder, polycystic kidney disease, urinary system disorder | Active, not recruiting | Not stated | 2026-09-09 | NCT06747572 | |
| Anatomical Shoulder Domelock System Study | Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, autoimmune disease, avascular necrosis, bone disorder, connective tissue disorder, immune system disorder, musculoskeletal system disorder, osteoarthritis, osteonecrosis, rheumatic disorder, rheumatoid arthritis | Active, not recruiting | Not stated | 2026-08-25 | NCT03312465 | |
| Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 3 | 2026-06-22 | NCT05696626 | |
| A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD) | Bronchiolitis Obliterans, bronchial disorder, bronchiolitis, bronchiolitis obliterans syndrome, bronchitis, cryptogenic organizing pneumonia, graft versus host disease, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Recruiting | Phase 2 | 2026-06-16 | NCT04710576 | |
| A Study of AL102 in Patients With Progressing Desmoid Tumors | Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, connective tissue neoplasm, desmoid tumor, fibroma, neoplasm | Active, not recruiting | Phase 2 / Phase 3 | 2026-06-08 | NCT04871282 | |
| Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN) | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder | Active, not recruiting | Phase 3 | 2026-05-15 | NCT06564142 | |
| The Minimally Invasive Coronary Surgery Compared to STernotomy Coronary Artery Bypass Grafting Trial | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, myocardial ischemia, vascular disorder | Active, not recruiting | Not applicable | 2026-05-12 | NCT03447938 | |
| Cardiopulmonary Toxicity of Thoracic Radiotherapy | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, cardiovascular disorder, digestive system disorder, digestive system neoplasm, esophageal disorder, hypertensive disorder, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, pulmonary hypertension, respiratory system disorder, respiratory tract neoplasm, vascular disorder | Recruiting | Not stated | 2025-03-25 | NCT03978377 | |
| The Elixir Bioadaptor vs. The Onyx Stent in De Novo Native Coronary Arteries | Arterial Occlusive Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, coronary stenosis, heart disorder, myocardial ischemia, vascular disorder | Active, not recruiting | Not applicable | 2025-03-24 | NCT04192747 | |
| Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose | Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder, portal hypertension | Recruiting | Phase 4 | 2025-01-28 | NCT04073290 |